FeesSafety
Pluang+

Arbitrum's Morpho market hits $115M TVL for USDG lending within 18 days of launch

Protocol Fundamentals
27 Oct 2026, 00:11 WIB
Tokenpost
View Source
Bullish
Arbitrum's Morpho market hits $115M TVL for USDG lending within 18 days of launch

The Morpho lending market on Arbitrum reached $115 million in total value locked (TVL) for Global Dollar (USDG) lending just 18 days after its launch. This figure reflects the lending activity on Morpho, not the total USDG circulation across networks. Users can both lend and borrow USDG through this platform. The USDG token was introduced on Arbitrum One by Paxos on October 6, with Morpho providing lending services from the start. Previously, the market's TVL was $44 million, showing rapid growth in lending demand.

The Global Dollar (USDG) lending market on Morpho reached a total value locked (TVL) of $115 million within 18 days of launch, indicating rapid growth in lending demand. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Oct 27, 2026 04:01 WIB: out of 50 major cryptocurrencies, 16 rose and 32 fell today. Notable movers include DOT (Polkadot) at Rp18.137 with a 27% Sell / 73% Buy order activity and a typical hold time of 122 days, FTM (Fantom) at Rp11.382 with a typical hold time of 88 days, and LUNC (Terra Classic) at Rp0,8 with a 49% Sell / 51% Buy order activity and a typical hold time of 196 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App